In a recent Phase III rare disease trial, IQVIA was challenged with and met a tight enrollment timeline. IQVIA’s real world data helped pinpoint the top 10% of physicians with active patients and significantly increased the patient pool.

Learn More

IQVIA Core-Powered Clinical Development. Our CORE-powered approach to clinical development dramatically increases speed and efficiency to help you bring your products to patients faster. • Accelerate site identification by up to 40%. • Increase patient enrollment by up to 30%. • Applied to more than 200 clinical studies.

Proof, not promises.

Learn More

Data based on a recent Phase III rare disease trial. Results may vary due to various factors.